We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00742339
Recruitment Status : Terminated (Decision of independent monitoring committee: Risk of non-response to treatment significantly higher in midodrine group than in terlipressin group.)
First Posted : August 27, 2008
Last Update Posted : October 15, 2014
Information provided by:
University of Padova

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : October 2013
Actual Study Completion Date : October 2013